+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
BioMarin Pharmaceutical Inc. - logo

BioMarin is a world leader in developing and commercializing innovative biopharmaceuticals for rare diseases driven by genetic causes. They are leaders in metabolic disease innovation with multiple products commercialized and a pipeline of product candidates to address unmet medical needs. BioMarin's headquarters are based in Novato, California, United States.

North America Rare Disease Therapeutics Market, Competition, Forecast & Opportunities, 2018-2028 - Product Thumbnail Image

North America Rare Disease Therapeutics Market, Competition, Forecast & Opportunities, 2018-2028

  • Report
  • October 2023
  • 120 Pages
  • North America
From
Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market by Scale of Operation, Type of Vector, Application Area, Therapeutic Area, and Geographical Regions: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market by Scale of Operation, Type of Vector, Application Area, Therapeutic Area, and Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • August 2022
  • 689 Pages
  • Global
From
AAV Vector Market: Focus on Drugs, Manufacturers and Technologies by Type of Therapy, Type of Gene Delivery Method Used, Target Therapeutic Area, Application Area, Scale of Operation and Geographical Regions: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

AAV Vector Market: Focus on Drugs, Manufacturers and Technologies by Type of Therapy, Type of Gene Delivery Method Used, Target Therapeutic Area, Application Area, Scale of Operation and Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • August 2022
  • 250 Pages
  • Global
From
Phenylketonuria (PKU) (Metabolic Disorder) - Drugs in Development, 2021 - Product Thumbnail Image

Phenylketonuria (PKU) (Metabolic Disorder) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Modified Release Neurology Therapeutics - Product Thumbnail Image

Modified Release Neurology Therapeutics

  • Report
  • January 2024
  • 125 Pages
  • Global
From
Europe Cell & Gene Therapy Market - Focused Insights 2024-2029 - Product Thumbnail Image

Europe Cell & Gene Therapy Market - Focused Insights 2024-2029

  • Report
  • June 2024
  • 103 Pages
  • Europe
From
Viral Vector Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Viral Vector Collaboration and Licensing Deals 2016-2024

  • Report
  • May 2024
  • 250 Pages
  • Global
From
Genomic Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Genomic Collaboration and Licensing Deals 2016-2024

  • Report
  • May 2024
  • 500 Pages
  • Global
From
Central Nervous System Collaboration and Licensing Deals 2019-2024 - Product Thumbnail Image

Central Nervous System Collaboration and Licensing Deals 2019-2024

  • Report
  • April 2024
  • 700 Pages
  • Global
From
Duchenne Muscular Dystrophy Disease - Global Clinical Trials Review, H2, 2020 - Product Thumbnail Image

Duchenne Muscular Dystrophy Disease - Global Clinical Trials Review, H2, 2020

  • Clinical Trials
  • October 2020
  • 211 Pages
  • Global
From
Pediatric Medicines: Global Markets - Product Thumbnail Image

Pediatric Medicines: Global Markets

  • Report
  • November 2019
  • 169 Pages
  • Global
From
Global Bleeding Disorders Testing Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Global Bleeding Disorders Testing Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Viral Vector and Plasmid DNA: Technologies and Global Markets - Product Thumbnail Image

Viral Vector and Plasmid DNA: Technologies and Global Markets

  • Report
  • March 2024
  • 128 Pages
  • Global
From
Gene Therapy - Global Strategic Business Report - Product Thumbnail Image

Gene Therapy - Global Strategic Business Report

  • Report
  • March 2024
  • 411 Pages
  • Global
From
Global Enzyme Replacement Therapy Market by Therapeutic Condition (Fabry Disease, Gaucher Disease, Mucopolysaccharidosis), Enzyme Type (Agalsidase Beta, Alglucosidase Alfa, Galsulfase), Route of Administration, End-User - Forecast 2024-2030 - Product Thumbnail Image

Global Enzyme Replacement Therapy Market by Therapeutic Condition (Fabry Disease, Gaucher Disease, Mucopolysaccharidosis), Enzyme Type (Agalsidase Beta, Alglucosidase Alfa, Galsulfase), Route of Administration, End-User - Forecast 2024-2030

  • Report
  • March 2024
  • 194 Pages
  • Global
From
Long-Acting Injectable Drugs - Product Thumbnail Image

Long-Acting Injectable Drugs

  • Report
  • December 2021
  • 170 Pages
  • Global
Haemophilia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Thumbnail Image

Haemophilia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • April 2024
  • 180 Pages
  • Global
From
US Cell & Gene Therapy Market - Focused Insights 2023-2028 - Product Thumbnail Image

US Cell & Gene Therapy Market - Focused Insights 2023-2028

  • Report
  • May 2023
  • United States
From
Breast Cancer Therapeutics Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Breast Cancer Therapeutics Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • September 2023
  • 120 Pages
  • Global
From
Endothelial Dysfunction Global Clinical Trials Review, H2, 2019 - Product Thumbnail Image

Endothelial Dysfunction Global Clinical Trials Review, H2, 2019

  • Clinical Trials
  • December 2019
  • 290 Pages
  • Global
From
Loading Indicator